AlphaStocks
7.4
Consider Buy

Teva Pharmaceutical Industries Ltd (TEVA)

As of Sep 20, 2026, Teva Pharmaceutical Industries Ltd (TEVA) scores 7.4/10 on AlphaStocks' five-model composite, #6 of 168 Health Care stocks. At $39, TEVA trades 20% above its model fair value of $33.

Health Care

ADR

$39.04

Above average across most dimensions. A solid candidate.

Consider Buy

Score based on 4 of 5 models — moderate confidence

Data as of Sep 20, 2026

#6out of 168 in Health Care

Is TEVA PHARMACEUTICAL INDUSTRIES LTD a Good Investment in 2026?

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) scores 7.4 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates TEVA PHARMACEUTICAL INDUSTRIES LTD as Strong (8/9). However, the Graham model rates it Caution — Significantly above fair value. TEVA PHARMACEUTICAL INDUSTRIES LTD currently trades 20% above its estimated fair value of $33. TEVA PHARMACEUTICAL INDUSTRIES LTD ranks #6 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E32.2ROE18.6Market Cap46B

Estimated Fair Value

$32.6320% above

Trading above estimated fair value — the market may be pricing in future growth.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Strong

8/9

Buffett

Attractive

Business quality & competitive moat

Graham

Caution

Significantly above fair value

Lynch

Attractive

Growth rate vs price (PEG)

Greenblatt

Strong

Earnings yield 13.7% · ROC >100%

Frequently Asked Questions

Is TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) a good investment?
As of Sep 20, 2026, Teva Pharmaceutical Industries Ltd (TEVA) scores 7.4/10 on AlphaStocks' five-model composite, #6 of 168 Health Care stocks. At $39, TEVA trades 20% above its model fair value of $33. That score is above average across most investment dimensions.
What is TEVA PHARMACEUTICAL INDUSTRIES LTD's Piotroski F-Score?
TEVA PHARMACEUTICAL INDUSTRIES LTD's Piotroski F-Score status is Strong. The raw score is 8/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is TEVA overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $33, TEVA appears overvalued. The stock currently trades 20% above its estimated fair value. Trading above estimated fair value — the market may be pricing in future growth.
How does TEVA compare to other Health Care stocks?
TEVA PHARMACEUTICAL INDUSTRIES LTD ranks #6 out of 168 stocks in the Health Care sector, placing it in the top 4% of its sector by composite score. This is a strong position relative to sector peers.
What do investment models say about TEVA?
AlphaStocks evaluates TEVA using five proven investment models. Piotroski: Strong; Buffett: Attractive; Graham: Caution; Lynch: Attractive; Greenblatt Magic Formula: Strong. These models are combined into a single composite score of 7.4/10.

Similar Stocks

INSPABBVINCY

Compare TEVA with

INSP vs TEVAABBV vs TEVAINCY vs TEVAAZN vs TEVABFAM vs TEVA

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer